Clinical trial
A Relative Bioavailability of 10 mg Citalopram Hydrobromide Tablets Under Fasting Conditions
NCT00865943 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Relative Bioavailability of 10 mg Citalopram Hydrobromide Tablets Under Fasting Conditions
- Lead sponsor
- Actavis Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- August 31, 2003
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy